Effect | None |
Trial Design | Double blind |
Trial Length | 1-6 months |
Number of Subjects | 22 |
Sex | Male |
Age Range | 18-29 |
Body Types | Average |
A loading phase of creatine followed by maintenance for 11 weeks in otherwise healthy sedentary males appears to reduce glucose following an oral glucose tolerance test (11-22%) with efficacy at 4 weeks and no further efficacy at 12 weeks; there was no significant influence on insulin sensitivity (assessed via HOMA) nor serum insulin.